Covidien's medical device business generated $2.14 billion in sales during the fiscal third quarter, a 3.7% increase from the same period last year. The segment also is expected to see sales growth of up to 5% during fiscal year 2014, Chief Financial Officer Charles Dockendorff said during the company's yearly investor meeting.

Related Summaries